Americafirst Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Americafirst Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-9,110	Closed	-$303K	–	246
2017 Q2	$303K	Buy	+9,110	New	+$282K	0.38%	89
2016 Q4	–	Sell	-32,767	Closed	-$1.51M	–	247
2016 Q3	$1.51M	Buy	+32,767	New	+$1.71M	1.25%	39
2015 Q1	–	Sell	-15,924	Closed	-$916K	–	339
2014 Q4	$916K	Sell	15,924 -33,864	-68%	-$1.89M	0.44%	75
2014 Q3	$2.68M	Buy	+49,788	New	+$2.64M	1.32%	12

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Americafirst Capital Management's TEVA Position: Q3 2017 in Review

Americafirst Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 9,110 shares — an estimated $303K sold.

Americafirst Capital Management first reported a position in TEVA in Q3 2014 and held it in 4 quarters. The position peaked at $2.68M in Q3 2014. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Americafirst Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
Americafirst Capital Management sold 9,110 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $303K.
Americafirst Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and held it in 4 quarters.
Americafirst Capital Management's Teva Pharmaceutical Industries Limited position peaked at $2.68M in Q3 2014.
537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.